Skip to main content

420 with CNW — Survey Shows Patients Satisfied with Marijuana as Neuropathy Treatment

A recent survey has found that marijuana is equally effective in alleviating neuropathy symptoms as opioids, raising questions about the validity of previous studies that utilized government-grown cannabis with lower potency. The survey was conducted by NuggMD, a company that connects patients with medical marijuana recommendations, and it involved 603 participants who used marijuana primarily or secondarily for neuropathy.

In the study, neuropathy, a painful condition, was measured by patients who assessed their pain levels on a scale of 1 to 10 both prior to…

Read More>>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published:

Do you have questions or are you interested in working with CNW420? Ask our Editor

Denver, Colorado
303.498.7722 Office

CNW420 is part of the InvestorBrandNetwork.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.